Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Medtronic (NY: MDT )

84.74 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Medtronic

< Previous 1 2 3 4 5 6 7 8 9
...
47 48 Next >
Where Will Medtronic Stock Be in 3 Years?
Can this struggling medical device maker turn things around? 
Via The Motley Fool
Expert Ratings For Medtronic
Via Benzinga
Is Medtronic Stock a Buy Now?
A dividend legend is navigating some bumpy waters right now. 
Via The Motley Fool
Why Medtronic Stock Jumped Today
The medical device leader announced strong quarterly results and raised its full-year outlook. 
Via The Motley Fool
Medtronic (MDT) Q3 2024 Earnings Call Transcript
MDT earnings call for the period ending December 31, 2023. 
Via The Motley Fool
Topics Earnings
Exposures Financial
4 Ultra-Safe Passive Income Vehicles to Buy and Hold Forever
These four dividend stocks won't keep you awake at night. 
Via The Motley Fool
Medtronic To Exit Unprofitable Ventilator Product Line, Boosts Annual Guidance On Strong Demand
Medtronic reports Q3 2024 sales of $8.1 billion, driven by major product approvals in diabetes, cardiac rhythm management, and more. Medtronic's move to exit the ventilator product line. 
Via Benzinga
Could Medtronic Stock Help You Become a Millionaire?
Medtronic has faced some headwinds in recent years, but its future should look brighter. 
Via The Motley Fool
How Is The Market Feeling About Medtronic?
Via Benzinga
Medtronic Surges Within A Consolidation On Its Strong Beat, Outlook Boost
The company beat expectations despite taking an 11-cent hit to adjusted earnings on exchange rates. 
Via Investor's Business Daily
Medtronic Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Medtronic plc (NYSE: MDT) is expected to release earnings results for its third quarter of fiscal year 2024, before the opening bell on Feb. 20, 2024. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
Don't count these companies out too soon. 
Via The Motley Fool
ChatGPT Stock Predictions: 3 Robotics & Automation Companies the AI Bot Thinks Have 10X Potential
Wager on these three AI-predicted top robotics stocks to buy that are poised for explosive long-term growth ahead. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Earnings Scheduled For February 20, 2024
Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue of $7.38 billion. 
Via Benzinga
Beyond Nvidia: How To Navigate Investing In Your 40s — Insights From Reddit
A Reddit user reached out to the community seeking advice beyond the hunt for the "next NVIDIA Corp." Here's a sample of the responses. 
Via Benzinga
A Turning Point in High Blood Pressure Management: Introducing The Symplicity Blood Pressure Procedure
(NewsUSA) - High blood pressure, also known as hypertension, is a growing epidemic that affects half of all Americans. High blood pressure can harm vital organs like your heart, brain, kidneys and eyes... 
Via NewsUSA
Un Momento Decisivo en el Manejo de la Presión Arterial Alta: Presentando el Procedimiento Symplicity para la Presión Arterial
(NewsUSA) - La presión arterial alta, también conocida como hipertensión, es una epidemia creciente que afecta a la mitad de todos los estadounidenses. La presión arterial alta puede dañar órganos... 
Via NewsUSA
February’s Smart Buys: 7 Value Stocks You Can’t Afford to Miss
Value stocks are set to enjoy their moment in the sun this year as cautious investors focus on fundamentals and long-term outlooks. 
Via InvestorPlace
Heart Month 2024: Professional Football Player Tackles Atrial Fibrillation and Stroke with Help from Cardiac Monitoring
(NewsUSA) - For professional athletes, being at your physical best and pushing your body to its limits is often what it takes to achieve success on the field. When a player is struggling to catch their... 
Via NewsUSA
7 Dividend Stocks Worth Holding for the Long Haul
These dividend stocks are worth holding for the long term both for upside and income production that can add up quickly. 
Via InvestorPlace
The 7 Best Healthcare Stocks to Invest In for Big Gains in 2024
Invest in the future with healthcare stocks 2024; offering a blend of market stability and cutting-edge medical advancements. 
Via InvestorPlace
The Diversification Conundrum of High Yield Stock Investing
You know not to put all of your investing eggs in one basket, but many dividend investors end up doing just that. 
Via The Motley Fool
Buy, Hold, Profit: 3 Dividend Stocks to Own Forever at Bargain Prices
Investors seem to have cycled out of them there are plenty of dividend stocks to own forever that are bargain buys. 
Via InvestorPlace
2 High-Yield Healthcare Stocks to Buy With Both Hands and 1 to Avoid for Now
All three of these stocks offer attractive dividend yields, but one looks risky. 
Via The Motley Fool
My Top-5 AI Growth Stocks to Buy Hand Over Fist for 2024
These stocks could deliver top returns now and well into the future. 
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Top 7 Value Stocks to Outperform Growth in 2024
Value stocks are set to surge in 2024 as economic uncertainty sends investors hunting for stability, profitability, and maturity over growth. 
Via InvestorPlace
3 Healthcare Stocks to Buy as the Sector Benefits from the Aging Boom
These three aging stocks offer different thematic approaches to profit from the opportunities that exist in an aging population. 
Via InvestorPlace
3 Blue-Chip Healthcare Stocks to Buy and Hold Forever: January 2024
Blue-chip healthcare stocks combine stability, profitability, and long-term growth prospects into a single investable package. 
Via InvestorPlace
Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analyst
Inari Medical with strong position in venous thrombectomy. Buy-rated by Needham with a $72 target. Undervalued shares with an 88% gross margin and anticipated double-digit revenue growth. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
47 48 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.